Christian’s Substack

Christian’s Substack

Home
Archive
About
ATAI acquires Beckley — establishing the clear leader in psychedelics
Today marks a very proud and emotional milestone: atai Life Sciences (Nasdaq: ATAI), the psychedelics medicine company I co-founded 2018, announced a…
Adding Natural Resources (Tech) to Apeiron’s investment universe - starting with Uranium
Most people know my investment firm, Apeiron Investment Group, for our work and investments in Biotech, Crypto, and Deep Tech.
Trump and Merkel: History Doesn’t Repeat Itself, But It Often Rhymes
At the height of the Euro crisis, I helped organize many high-level meetings between German government officials and international investors.
What psychedelics and Bitcoin have in common
In short: Both stand for freedom
Why Bitcoin can be a valid part of a corporate treasury – especially in the biotech sector
In an era of persistent inflation and volatile markets, I find myself asking an important question for biotech companies looking to preserve and…
1
I just invested $22.75m more into atai Life Sciences: here's why
I am very happy to announce that within the recently completed capital raise of atai Life Sciences (Nasdaq: ATAI) of a total of USD 63.25 million (in…
Activists are not necessarily drug developers
My opinion on the FDA Advisory Committee hearing on MDMA and what it means for atai
1
Christian’s Substack
Christian’s Substack
My personal Substack
Recommendations
Alice in Futureland
Alice in Futureland
Alice in Futureland
European Blockchain Convention
European Blockchain Convention
Victoria Gago

Christian’s Substack

AboutArchiveRecommendationsSitemap
© 2025 Christian Angermayer
Privacy ∙ Terms ∙ Collection notice
Start writingGet the app
Substack is the home for great culture